Cholesterol Rewritten: Verve’s Base Editing Therapy May Disrupt a $20B Market
High cholesterol has long been a silent threat lurking in
A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads
When Dr. Peter Marks walked out of the FDA’s headquarters
Diamond Biofund Becomes First Biotech VC Firm Listed on Taiwan Stock Exchange
Introduction: Diamond Biofund has recently achieved a groundbreaking milestone by
MOST POPULAR
